Skip to main content
    R

    Rein Therapeutics Inc (RNTX)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.75
    -0.03 (-3.86%)

    Market Cap: $65.10M

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    50%(17/34)
    Avg Surprise
    -41.83%
    Streak
    2 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$-0.10
    Range$-0.10 - $-0.10
    2 analysts
    EPS Revisions
    1
    0
    7d
    1
    0
    30d
    EPS Estimate DriftChange to current
    90d ago$-0.35+71.4%
    60d ago$-0.100.0%
    30d ago$-0.100.0%
    7d ago$-0.09-11.1%
    Current$-0.10
    Revenue Consensus
    $0
    Range$0 - $0
    2 analysts
    Period ending Dec 31, 2026
    EPS Consensus$0.30
    Range$0.29 - $0.31
    2 analysts
    Revenue Consensus
    $0
    Range$0 - $0
    2 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$0.30---
    Sep 26EST
    		-$-0.10---
    Jun 26
    Reported Aug 14
    		$-0.10N/A+62.96%Beat+64.3%
    Mar 26
    Reported May 15
    		$-0.19N/A+61.22%Beat+24.0%
    Dec 25
    Reported Mar 26
    		$-1.22$-0.21-467.44%Miss-366.9%
    Sep 25
    Reported Nov 14
    		$-0.21$-0.24+12.50%Beat+22.2%
    Jun 25
    Reported Aug 14
    		$-0.28$-0.22-27.27%Miss+37.8%
    Mar 25
    Reported Apr 7
    		$-0.25$-0.21-19.05%Miss+70.9%
    Dec 24
    Reported Dec 31
    		$-0.26$-0.48+45.56%Beat+83.0%
    Sep 24
    Reported Nov 14
    		$-0.27$-0.35+22.86%Beat+32.5%
    Jun 24
    Reported Aug 14
    		$-0.45$-0.42-7.14%Miss-14.4%
    Mar 24
    Reported May 15
    		$-0.86$-1.02+15.69%Beat+18.1%
    Dec 23
    Reported Dec 31
    		$-1.54$-0.16-862.50%Miss-54.0%
    Sep 23
    Reported Oct 13
    		$-0.40$-0.20-100.00%Miss+71.4%
    Jun 23
    Reported Aug 8
    		$-0.39N/AN/ABeat+78.1%
    Mar 23
    Reported May 8
    		$-1.05$-0.60-75.00%Miss+41.7%
    Dec 22
    Reported Mar 20
    		$-1.00$-1.34+25.37%Beat-1150.0%
    Sep 22
    Reported Nov 1
    		$-1.40$-1.60+12.50%Beat+0.0%
    Jun 22
    Reported Aug 15
    		$-1.80$-1.90+5.26%Beat-50.0%
    Mar 22
    Reported May 5
    		$-1.80$-1.60-12.50%Miss-12.5%
    Dec 21
    Reported Mar 28
    		$-0.08$-0.08+0.00%Beat+33.3%
    Sep 21
    Reported Nov 12
    		$-1.40$-1.40+0.00%Beat+46.2%
    Jun 21
    Reported Aug 11
    		$-1.20$-1.40+14.29%Beat+57.1%
    Mar 21
    Reported May 11
    		$-1.60$-1.10-45.45%Miss+66.7%
    Dec 20
    Reported Mar 24
    		$-0.12$-0.13+5.81%Beat+53.8%
    Sep 20
    Reported Nov 12
    		$-2.60$-2.75+5.45%Beat+53.6%
    Jun 20
    Reported Aug 5
    		$-2.80$-3.73+24.93%Beat+46.2%
    Mar 20
    Reported May 11
    		$-4.80$-4.20-14.29%Miss+51.0%
    Dec 19
    Reported Mar 30
    		$-0.26$-0.27+3.70%Beat+97.4%
    Sep 19
    Reported Nov 7
    		$-5.60$-4.75-17.89%Miss+56.3%
    Jun 19
    Reported Aug 6
    		$-5.20$-4.45-16.85%Miss+50.0%
    Mar 19
    Reported May 8
    		$-9.80$-7.75-26.45%Miss-8.9%
    Sep 18
    Reported Nov 7
    		$-10.00$-11.10+9.91%Beat-20.9%
    Jun 18
    Reported Aug 7
    		$-12.80$-10.40-23.08%Miss-
    Mar 18
    Reported May 9
    		$-10.40$-10.00-4.00%Miss-
    Sep 17
    Reported Nov 9
    		$-9.00$-6.90-30.43%Miss-
    Jun 17
    Reported Aug 10
    		$-8.27$-8.20-0.85%Miss-

    Key Metrics

    Valuation
    P/E Ratio-0.44EV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin0.00%Operating Margin0.00%
    ROE-96.40%ROICN/A
    Financial Health
    Debt/Equity0.00xInterest CoverageN/A
    Current Ratio4.27xQuick Ratio4.27x
    Trading Statistics
    Beta1.35Avg Volume345.66K
    52-Week High$2.1852-Week Low$0.69

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$0.80
    SMA 20$0.78
    SMA 50$0.79
    SMA 200$1.07
    EMA 10$0.79
    EMA 20$0.79
    EMA 50$0.81
    EMA 200$1.03

    MACD

    Line: -0.00Signal: -0.00Hist: -0.00

    ADX

    ADX: 19.4+DI: 20.3-DI: 15.7

    Aroon & PSAR

    Aroon UpN/A
    Aroon Down24.0
    PSAR$0.90

    Bollinger Bands

    Upper Band$0.85
    Lower Band$0.71
    %B Position1821%(Upper)
    Band Width0.30

    RSI (14-Day)

    Neutral
    44.9

    Momentum Oscillators

    Stoch %K34.3
    Stoch %D36.3
    Williams %R-78.3
    ROC (10d)-4.5%
    Momentum-0.04
    CCI (20d)-62.2
    MFI (14d)54.7

    Volatility Measures

    ATR (14d)$0.06(7.9%)
    StdDev (20d)0.04
    Hist Vol74.3%(High)

    Volume Flow

    VWAP$0.76
    OBV36.0M
    AD Line-29.1M
    CMF (20d)-0.079

    Volume Metrics

    Avg Vol (20d)335.1K
    Vol Ratio0.4x(Low)
    VWMA (20d)$0.79

    Pivot Points

    R3$0.84
    R2$0.81
    R1$0.80
    Pivot Point$0.77
    S1$0.76
    S2$0.74
    S3$0.72

    Advanced Oscillators

    TSI-1.37
    Ultimate Osc45.7
    KST6.49

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$0$0$0$0$0$0$0$0$0$0$0$0
    Cost of Revenue$0$0N/A$0$0$0N/A$0$0$0N/A$0
    Gross Profit$0$0N/A$0$0$0N/A$0$0$0N/A$0
    Operating Expenses$6.08M$5.23M$32.66M$5.49M$6.87M$5.61M$42.80M$6.07M$9.04M$7.21M$7.29M$1.98M
    R&D$3.64M$3.07M$2.00M$1.68M$4.29M$3.05M$3.32M$3.72M$3.74M$3.46M$1.97M$22,000
    SG&A$2.44M$2.16M$1.96M$3.81M$2.58M$2.56M$2.48M$2.35M$5.30M$3.74M$5.33M$1.96M
    Operating Income$-6,076,000$-5,230,000$-32,659,000$-5,492,000$-6,871,000$-5,609,000$-42,797,000$-6,071,000$-9,039,000$-7,205,000$-7,290,000$-1,983,000
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$299,000$608,000$20,000$89,000$0$0$0$0$0$0$49,000$0
    Income Before Tax$-6,375,000$-5,838,000$-32,679,000$-5,581,000$-6,822,000$-5,501,000$-42,525,000$-5,847,000$-8,942,000$-7,113,000$-7,339,000$-1,827,000
    Income Tax Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Net Income$-6,375,000$-5,838,000$-31,967,000$-5,581,000$-6,822,000$-5,501,000$-40,981,000$-5,847,000$-8,942,000$-7,113,000$-7,339,000$-1,827,000
    EBITDA$-5,923,000$-5,215,000$-32,679,000$-5,581,000$-6,821,000$-5,501,000$-42,525,000$-5,847,000$-8,938,000$-7,054,000$-7,099,000$-1,816,000
    EBIT$-6,375,000$-5,838,000$-32,679,000$-5,581,000$-6,822,000$-5,501,000$-42,525,000$-5,847,000$-8,942,000$-7,113,000$-7,339,000$-1,827,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about RNTX

    RNTX Valuation and Fair Value

    P/E
    -0.4x
    P/B
    5.0x
    See GNG's fair value

    RNTX Profitability: Margins, ROIC and FCF

    Operating margin
    0.0%
    Net margin
    0.0%
    ROE
    -96.4%

    RNTX Competitors

    CompanyTicker
    Verrica Pharmaceuticals IncVRCA
    OS Therapies IncorporatedOSTX
    XBiotech IncXBIT
    ImmunoPrecise Antibodies Ltd.HYFT
    Neumora Therapeutics, Inc.NMRA
    MDxHealth SAMDXH
    Champions Oncology IncCSBR
    ZEN Graphene Solutions LtdZTEK

    Sector: Healthcare

    RNTX Earnings: Beat Rate and Next Report

    Beat rate
    5 of 8 quarters (62.5%)
    Average surprise
    -38.6%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $-0.10
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    1 up, 0 down

    Frequently Asked Questions About RNTX

    Does RNTX pay dividends?

    Rein Therapeutics Inc (RNTX) does not currently pay a regular dividend.

    What is RNTX's market cap?

    Rein Therapeutics Inc (RNTX) has a market capitalization of $65.10M with a current stock price of $0.75.

    Related stocks

    Sector: Healthcare

    All stocks starting with R

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In